Skip to content
Search

Latest Stories

New report reveals small rise in NHS dental workforce in England

New report reveals small rise in NHS dental workforce in England

More than 30 million courses of dental treatment were delivered in 2023/24 in England  

A new report published by the NHS Business Services Authority (NHSBSA) reveals that 24,300 dentists performed NHS dental activity in England in 2023/24, marking a 0.4 per cent rise from the previous year’s 24,227.

However, this figure represents a 1.5 per cent decrease from 24,700 dentists with NHS activity in 2019/20.


The report covers NHS dental activity and the NHS dental workforce in England from 2019/20 to 2023/24.

It is the first release from NHSBSA following the transition from NHS England, which previously issued the report.

There were 34 million courses of dental treatment in England for 2023/24, a 4.3 per cent increase from 2022/23. The total units of dental activity (UDAs) rose by 3.4 per cent to 73 million.

Other key findings include:

  • There were 18 million adult patients seen in the 24 months up to the end of March 2024
  • There were 6.7 million child patients seen in the 12 months up to the end of March 2024
  • Courses of treatment for adults increased by 2.2 per cent to 23 million, while those for children rose by 9.0 per cent to 11.2 million.
  • Among child treatment courses, more than 56 per cent included fluoride varnish.

The total number of units of dental activity awarded to dental activity claims was 72.5 million in 2023/24, reflecting a 3.4 per cent increase from the previous year but a 9.1 per cent decrease from the 79.7 million UDAs in 2019/20.

Total revenue from patient charges amounted to £774 million in 2023/24, a 2.7 per cent increase from £754 million the previous year.

In February 2024, the previous government introduced the NHS dental recovery plan, backed by £200 million in funding. The plan was designed to provide over 1.5 million additional NHS dental treatments or up to 2.5 million NHS dental appointments within the next 12 months.

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less